SCHEMBL4694436

SCHEMBL4694436

NCc1ccc(C(=O)NCCOC(=O)N(c2ccccc2-c2ccccc2)N2CC[CH]CC2)o1

nearest known ligand 0.38

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
ALDH1A1 P00352 7/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
HPGD P15428 3/20 0.36
TSHR P16473 3/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
TDP1 Q9NUW8 2/20 0.33
LMNA P02545 3/20 0.33
MAPT P10636 2/20 0.33
ALOX15 P16050 1/20 0.33
HTT P42858 1/20 0.33
TAAR1 Q96RJ0 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4693976 0.89 NPC1 (0.36) NPC1RAB9AALDH1A1KMT2AMEN1
SCHEMBL5722183 0.87 HPGD (0.40) ALDH1A1KMT2AMEN1HPGDSMN1; SMN2
SCHEMBL2639950 0.86 CHRM2 (0.37) NPC1RAB9AALDH1A1KMT2A
SCHEMBL5272613 0.85 PDCD1 (0.38) NPC1RAB9AALDH1A1KMT2AMEN1
SCHEMBL5278178 0.84 ALDH1A1 (0.35) ALDH1A1HPGD
SCHEMBL5810881 0.81 SMN1; SMN2 (0.37) ALDH1A1HPGDSMN1; SMN2LMNAMAPT
SCHEMBL2639463 0.80 KDM4E (0.46) RAB9AALDH1A1KMT2AHPGDMAPT
SCHEMBL4695511 0.78 PDCD1 (0.34) SMN1; SMN2HTT
SCHEMBL5281472 0.77 TAAR1 (0.37) ALDH1A1KMT2AMEN1SMN1; SMN2HTT
SCHEMBL5272930 0.76 SPHK2 (0.34) ALDH1A1KMT2AMEN1HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1893577-A1 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS Theravance, Inc. (US) 2008-03-05 EP disclosed
WO-2006138218-A1 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS THERAVANCE, INC. (US) 2006-12-28 WO disclosed